Speakers

 

Prof David Bennett (Oxford, UK)

David Bennett is Professor of neurology and neurobiology at the University of Oxford and consultant neurologist at Oxford University Hospitals in the UK. He is head of the Division of Clinical Neurology at the University of Oxford and a senior research fellow of Green Templeton College. His research focus is to understand the pathogenesis of neural injury and neuropathic pain and ultimately improve the clinical management of this debilitating condition. He takes a translational approach ranging from cell based models to human psychophysics and clinical cohorts. He administers a specialist neuropathic pain clinic based at Oxford University hospitals. He has led the identification of novel clinical neuropathies and inherited pain channelopathies. He leads major international and national consortia including DOLORisk and PAINSTORM investigating risk factors and determinants of neuropathic pain. 

David received the PD Wall medal from the Royal College of Anaesthetists in 2016 and became an honorary Skou professor of Aarhus University in 2019. He was appointed to Fellowship if the Academy of Medical Sciences in 2020 for excellence in pain research.

Prof Felicity Bishop (Southampton, UK)

Flis Bishop is a Professor of Health Psychology at the University of Southampton where she leads a programme of mixed methods research around complementary therapies and placebo effects in health care. Her interdisciplinary research has attracted funding from NIHR, Versus Arthritis, and others, and is published in medical, health psychology, and social science journals. 

With an extensive network of national and international collaborations, Flis has held visiting positions at Harvard and at the Australian Centre for Integrative and Complementary Medicine at UTS. Her current focus is on developing and testing novel and engaging ways to harness placebo effects in medical practice.

Prof Zameel Cader (Oxford, UK)

Professor Zameel Cader is a clinician-scientist, leading a neuroscience research group based in the Dorothy Crowfoot Hodgkin Building, University of Oxford. He is also founder and director for Oxford StemTech and Human Centric DD. His academic research programme is focused on understanding the disease process in migraine and pain using omics, human stem cell disease models and preclinical in vivo models.

Dr Samantha Cruz Rivera (Birmingham, UK)

Samantha Cruz Rivera is a Research Fellow at the Centre for Patient Reported Outcomes Research (CPROR), University of Birmingham. She has experience in trials methodology, systematic reviews, qualitative research and patient and public involvement activities. 

Her primary research interests are maximising research impact, EDI, AI and outcomes research including methods to optimise patient reported outcome assessment in clinical trials and routine practice.

Prof Helen Dawes (Exeter, UK)

Helen Dawes is Professor of Clinical Rehabilitation in the College of Medicine and Health. Helen has a clinical academic background as a physiotherapist and exercise scientist with an ambition to enable people living with conditions affecting their movement to be able to move more. 

Her research involves working closely, with industry, clinicians, and the public, to develop, evaluate and translate to clinical practice transformative innovation. In her role, Helen will be exploring the development of effective personalised, scalable, rehabilitation innovations to address the growing global need.

Prof John Dawes (Oxford, UK)

John Dawes is an Associate Professor in the Clinical Neurosciences Department at the University of Oxford and currently holds an MRC New Investigator Award. He is interested in the role of the immune system in chronic pain, in particular that of autoantibodies which can target antigens within the nervous system. 

His lab uses preclinical models to understand the mechanisms by which patient antibodies impact neuronal function and in doing so uncover novel molecular pathways contributing to clinical pain.


Prof Merle Fairhurst (Dresden, Germany)

Merle Fairhurst holds the chair for Social Affective Touch at the Technische Universität Dresden. She is a cognitive neuroscientist with strong interdisciplinary ties that facilitate crosstalk with engineers, computer scientists, clinicians and philosophers. She studies the interaction between sensory signals that allow us to make sense of the world around us and to successfully interact with others. 

Based at the Excellence Cluster, CeTI, her current research focuses on trying to better understand the (super) power of touch, a topic covered in her recent TedX talk. As a mother of five, she strongly believes in promoting women in academia.


Prof Alex Green (Oxford, UK)

Alexander L Green FRCS(SN), MD, MB BS, BSc(hons) PhD is a Professor of Neurosurgery at the University of Oxford, Nuffield Department of Surgical Sciences. He is an academic Functional Neurosurgeon specialising in Deep Brain Stimulation and Spinal Cord Stimulation but his practice also encompasses some general neurosurgery including trauma. 

Alexander's research is focused on Neuromodulation for Pain, Autonomic Function and Sleep disorders and includes device development, basic physiological science, and Neuroscience. He has authored over 200 peer-reviewed publications. He has been awarded a number of international prizes for his work, including the Congress of Neurological Surgeons (CNS) ‘Stereotactic and Functional Neurosurgery Resident Award’ in 2005, ‘Gordon Holmes Prize’ awarded by the Royal Society of Medicine in 2007, and the International Neuromodulation Society (INS) ‘New Investigator Award’ in 2010.

Prof Karin Jensen (Stockholm, Sweden)

Karin Jensen is a Professor for Cognitive Neuroscience at the Department of Clinical Neuroscience at the Karolinska Institute in Stockholm. Her research group focuses on brain mechanisms involved in the experience of pain and placebo effects. 

Karin’s work has challenged existing models of the placebo effect and contributed novel scientific data demonstrating that (a) placebos work outside of conscious awareness, (b) placebos work among patients with severe intellectual disabilities, and (c) placebo effects are shaped by subtle social cues between a patient and health-care provider. Recently, her research group has performed experimental studies on pain regulation in individuals with self-injury behavior.

Megan Jones (Oxford, UK)

Megan Jones is a passionate advocate and patient champion of the Pain Theme within the Oxford Biomedical Research Council's Patient and Public Involvement Panel (PPIP). Despite battling fibromyalgia, endometriosis, and adenomyosis, Megan is dedicated to advancing research and improving outcomes for fellow chronic pain sufferers. Recognised with the NHS Parliamentary Award "Rising Star" for the South East of England in 2023, she has raised vital funds and increased awareness about chronic pain conditions. 

Currently pursuing a Master of Science in Public Health at King's College London, Megan aims to blend lived experience with academic expertise to drive impactful change in healthcare policy and research. With courage, compassion, and unwavering dedication, she is working for a future where chronic pain is better understood and managed.


Prof Willem Kuyken (Oxford, UK)

Willem Kuyken is the Ritblat Professor of Mindfulness and Psychological Science at the University of Oxford, United Kingdom. His work focuses on preventing depression, promoting mental health, and flourishing across the lifespan. He has published more than 150 journal articles and was named by Web of Science as in the top 1% of the most cited scientists in the world in 2019, 2020, 2021, 2022, and 2023. 

Together with Christina Feldman, he wrote Mindfulness – Ancient Wisdom Meets Modern Psychology, published in 2019. His work has been featured in the New York Times, New Scientist, Nature, Scientific American, Times Educational Supplement, the BBC, CBS, New Statesman, Le Monde, der Zeit,  the Telegraph, and the Guardian. He lives in London.


Dr Scott Lempka (Michigan, US)

Scott F. Lempka, PhD, is an Associate Professor in the Department of Biomedical Engineering at the University of Michigan (Ann Arbor, MI, USA) with a secondary appointment in the Department of Anesthesiology. Dr. Lempka is the Principal Investigator of the Neuromodulation Laboratory and the Director of Neuromodulation in the Chronic Pain and Fatigue Research Center. His research group utilizes engineering approaches, such as computational modeling, to study the mechanisms of action of clinical neuromodulation therapies for chronic pain management and other neurological disorders. Prior to joining the University of Michigan in 2017, Dr. Lempka earned a B.S. in Biomedical Engineering from Saint Louis University (St. Louis, MO, USA) in 2004 and a M.S. and Ph.D. in Biomedical Engineering from Case Western Reserve University (Cleveland, OH, USA) in 2008 and 2010. 

His dissertation work focused on the use of computational and experimental techniques to characterize the interface between neural stimulation and recording electrodes and the surrounding tissue. He performed his postdoctoral training at the Cleveland Clinic and the Louis Stokes Cleveland VA Medical Center (Cleveland, OH, USA) in the area of neurostimulation for chronic pain management.

Pranhav Mahajan (Oxford, UK)

Pranav Mahajan is a DPhil student with Dr Ben Seymour and Dr Ioannis Havoutis. His research interests are focused on safe learning, generally trying to understand how humans and animals keep themselves safe, from a computational and algorithmic perspective and then using that knowledge to build safer machines. He employs emerging technologies such as virtual reality in his experiments and ideas from machine learning to build computational models of animal learning and cognition. 

In recent years, he has been motivated to help understand pathways to persistent pain from a computational lens.

Douglas Nelson (Champaign, US)

Douglas Nelson is Board Certified in Massage Therapy and Therapeutic Bodywork, beginning his career in massage therapy in 1977.  Seeing over 1,200 client visits annually, he runs a massage therapy clinic in Champaign, IL. with 21 therapists that was established in 1982.  


He has personally taught more than 13,000 hours of continuing education. Doug is a past president of the Massage Therapy Foundation.

 

Having published many articles in numerous journals and magazines, he is also the author of three books, Table Lessons: Insights in the practice of Massage Therapy (two volumes) and The Mystery of Pain. Doug is the recipient of the 2013 Educator of the Year and 2015 Pioneer Award by the Illinois Chapter of the AMTA and was inducted into the Massage Therapy Hall of Fame in 2018. 


Dr Temitayo Olugbade (Sussex, UK)

Temitayo Olugbade is a Lecturer in Computer Science and AI at University of Sussex and Honorary Research Fellow at University College London (UCL). Her research pursues development and application of AI (machine learning) methods to automatic detection of affective experiences and behaviours.

Dr Jane Quinlan (Oxford, UK)

Jane Quinlan studied medicine and trained in anaesthesia in London before moving to Oxford.  She is a consultant in anaesthesia and pain management at the Oxford University Hospitals NHS Foundation Trust, and is an honorary senior clinical lecturer at the University of Oxford.  She is past secretary of the Acute Pain Special Interest Group (APSIG) for the International Association for the Study of Pain and past chair of APSIG of the British Pain Society.

Jane has an interest in prescribed opioid dependence and runs a clinic supporting pain patients to reduce high-dose opioids.  She also has an interest around the safe prescribing of opioids in postoperative pain to avoid the conversion to long-term use. She sits on the editorial board of the British Journal of Pain, and is on the organising committee of the National Acute Pain Symposium.

Prof Annina Schmid (Oxford, UK)

Annina Schmid is a Specialist Musculoskeletal Physiotherapist and a Professor of Pain Neurosciences at the Nuffield Department of Clinical Neurosciences at Oxford University in the UK. She leads the Neuromusculoskeletal Health and Science Lab which uses a translational and interdisciplinary approach to study the pathophysiology of neuromusculoskeletal conditions with the ultimate goal to improve management for patients. Annina has a particular interest in entrapment neuropathies and neuropathic pain and the development of precision therapy for these patients.  She has trained over 25 scientists and clinicians in her lab and maintains a strong international collaborative network.

Annina's research contributions have been recognised by the award of several prizes (most recently the Emerging Leaders Prize in Pain Research, Medical Research Foundation) and competitive fellowships. She was the first allied health professional to win a prestigious Clinical Research Career Development Fellowship from the Wellcome Trust. In addition to her research activities, Annina maintains a weekly caseload as a specialist musculoskeletal Physiotherapist.


Dr Louise Sell (Greater Manchester, UK)

Louise Sell is a consultant psychiatrist at Pennine Care, Greater Manchester. She has an extensive background working as an Addiction Psychiatrist and Service Director in Greater Manchester and Lancashire. She has undertaken research on the neural mechanisms underlying craving for opioids and has researched and written on aspects of service provision, particularly injectable opioid maintenance. She has taught on the treatment of opioid dependence on the British Association of Psychopharmacology certificate. Dr Sell graduated in medicine from Cambridge and London Universities and trained in psychiatry at Oxford and the Maudsley before moving to the Northwest. 

In addition to her clinical career she has worked as an Executive Medical Director and is currently a Non-Executive Director at Stockport NHS Foundation Trust. She is a Trustee of Early Break, a charity providing substance misuse and mental health treatment for young people. Dr Sell has contributed to Department of Health and Social Care / Public Health England guidelines on substance misuse and is currently Chair of the expert group writing UK Clinical guidelines for the treatment of alcohol use disorders. She has held several roles with the Royal College of Psychiatrists and is currently leading work to increase the availability of training in addiction psychiatry. Her most recent clinical role was in Bury Integrated Pain Service, working with a team of physiotherapists, mental health nurse, psychologists and anaesthetist to transform the assessment and management of persistent pain.

Prof Shafaq Sikandar (London, UK)

Shafaq Sikandar is a Professor of Sensory Neurophysiology and the group leader of the Sensory Neurophysiology lab at the William Harvey Research Institute. Her research training was based on rodent and human models to study the neurophysiology of pain. Shafaq’s PhD training was in the Pharmacology department of University College London, and she continued postdoctoral training in the Anaesthesiology department of University of California San Diego and in the Wolfson Institute of Biomedical Research of UCL. In 2018 she was awarded a Versus Arthritis fellowship and appointed lecturer in sensory biology in the Centre for Experimental Medicine & Rheumatology.

Shafaq teaches on BSc modules Repair & regeneration (BMD361) / Disconnected pathways (ICM6013) and is the FMD Equality Diversity and Inclusion Lead for Communications and Engagement.

Prof Rebeccah Slater (Oxford, UK)

Rebeccah Slater is the Professor of Paediatric Neuroscience and Senior Wellcome Fellow at the University of Oxford. She is also a Professorial Fellow at St. John’s College. 

Her work focuses on understanding the mechanisms that underlie the development of human pain perception, where she uses non-invasive brain imaging tools to explore the development of pain perception in the human nervous system. A focus of Rebeccah’s work is to provide a better mechanistic understand of whether parental touch can provide comfort and pain relief in infants. She designs and develops clinical trials that aim to assess the analgesic efficacy of pain relieving interventions.


Dr Emily Stanyer (Oxford, UK)

Emily Stanyer is a postdoctoral researcher in the Experimental and Clinical Sleep Medicine laboratory at the University of Oxford. She focuses on the mechanistic relationships between sleep, health, and disease, aiming to understand particularly how sleep may contribute to mental health disorders. Specifically, her work aims to investigate in an RCT whether sleep restriction therapy for insomnia alleviates depression and to elucidate potential underlying mechanisms. 

She completed her PhD at King's College London, where she utilised preclinical models to investigate the neural mechanisms of sleep and migraine. Prior to this, she worked at the University of Leeds on the impact of closed-loop auditory stimulation during sleep on memory consolidation.

Dr Stephanie Tierney (Oxford, UK)

Stephanie Tierney is a senior researcher at the Nuffield Department of Primary Care Health Sciences whose research interests include long-term conditions, delivery of services and patients' experiences of care. 

She is leading a programme of research focused on social prescribing as a means of supporting people with issues that cannot be treated with medication or medical procedures (e.g. loneliness, financial worries, housing problems). This research includes exploring the introduction of link workers into primary care and investigating how cultural providers and creative activities can be a means of sustaining people's well-being as part of social prescribing.

Shuangyi Tong (Oxford, UK)

Shuangyi Tong obtained his Bachelor of Mathematics degree at the University of Waterloo in Canada. During his 5-year undergraduate program, he had experience working in multiple industry software positions and computer system research. He started his DPhil course in 2020 under the supervision of Prof Ben Seymour and Prof Timothy Denison. 

Shuangyi's current research focuses on modelling pain mechanisms that serve as one of the foundations for closed-loop neuromodulation treatment for pain. He utilises new technology like virtual reality to develop immersive tasks. This VR experiment infrastructure with extensive sensors and stimulation methods is transferrable to various neurophysiological research.


Prof Irene Tracey (Oxford, UK)

Irene Tracey is currently Vice-Chancellor of the University of Oxford, her alma mater. She is also Professor of Anaesthetic Neuroscience in the Nuffield Department of Clinical Neurosciences. 

Over the past 25 years her multidisciplinary research team has contributed to a better understanding of pain perception, pain relief and nociceptive processing within the injured and non-injured human central nervous system using advanced neuroimaging techniques and novel paradigm designs.

Irene has served and continues to serve on many national and international committees, such as the International Association for the Study of Pain (IASP), British Neuroscience Association and Lundbeck Brain Prize Committee. She is currently appointed by the Government to the Council of the Medical Research Council and is President-elect of the Federation of European Societies (FENS). She is a passionate advocate for women in science and is involved in several mentorship schemes. In 2008 she was awarded the triennial Patrick Wall Medal from the Royal College of Anaesthetists and in 2009 was made an FRCA for her contributions to the discipline. In 2015 she was elected a Fellow of the Academy of Medical Sciences and in 2017 won the Feldberg Foundation Prize followed in 2018 by the British Neuroscience Association’s Outstanding Contribution to Neuroscience award and in 2020 she was elected a Member of the Academia Europaea. In the New Year’s Honours list 2022, she was appointed a Commander of the Order of the British Empire (CBE) by Her Majesty The Queen for services to Medical Research. 

Amanda Wall (Oxford, UK)

Amanda Wall is a physiotherapist by background, specialising in chronic pain and fatigue management. She currently works part time the in Chronic Fatigue Service at Oxford University Hospitals NHS Foundation Trust, and part time as a Research Assistant with the Nuffield Department of Clinical Neurosciences (NDCN), University of Oxford. 

Amanda has been involved in various research projects conducted within the Pain Group at NDCN, with a focus on fibromyalgia and sleep. She is now undertaking a PhD part time, investigating the effects of an online sleep intervention for fibromyalgia patients. 

Dr Jackie Walumbe (Oxford, UK)

Jackie Walumbe is an advanced practice physiotherapist at University College London Hospitals NHS Foundation Trust. Jackie works with multidisciplinary teams and is involved in the management of complex pain across specialities. She is an independent prescriber and clinical researcher. 

Jackie completed her DPhil (PhD) in Primary Health Care at the Nuffield Department of Primary Health Care Sciences, University of Oxford as part of a NIHR/HEE funded Clinical Doctoral Research Fellowship in 2022. Her research focused on understanding how self-management is understood and enacted by people living with chronic pain, and how they are supported in policy and practice using mixed qualitative methods. Jackie is a Topol Digital Health Fellow alumnus (Cohort 3) where she explored digitally enabled solutions to support people living with chronic pain. Her current research interests are in applied  critical scholarship in rehabilitation with a health equity focus.

Nicola Warrick (Oxford, UK)

Nicola Warrick (MHSc) did her Masters of Health Science in Canada and worked as a Speech and Language Therapist/Pathologist and researcher there before coming to Oxford to do a DPhil (PhD) in experimental psychology. A neck injury in 1993 prevented the completion of this degree and she was diagnosed with fibromyalgia in the mid-1990s. She has lived her whole life with pain from various conditions including hypermobility, essential tremor, endometriosis and osteoarthritis resulting in joint replacements and surgeries, alongside the fibromyalgia.


Nicola brings the lived experience of a long term chronic pain patient with wide first hand knowledge of various treatments, therapies and medications as well as the perspective of a parent living with pain, a clinician and an academic researcher.